tiprankstipranks
Trending News
More News >
Hemostemix Inc (TSE:HEM)
:HEM
Canadian Market

Hemostemix (HEM) Income Statement

Compare
16 Followers

Hemostemix Income Statement

Last quarter (Q4 2024), Hemostemix's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q4, Hemostemix's net income was C$-2.30M. See Hemostemix’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ 0.00C$ -223.00C$ -495.00C$ -1.10KC$ -2.45K
Operating Expenses
C$ 1.98MC$ 1.95MC$ 4.58MC$ 6.66MC$ 7.46M
Depreciation and Amortization
C$ 100.00C$ 223.00C$ 495.00C$ 1.10KC$ 2.45K
EBITDA
C$ -1.98MC$ -1.95MC$ -4.39MC$ -6.45MC$ -7.47M
Operating Income
C$ -1.98MC$ -2.33MC$ -4.58MC$ -6.67MC$ -7.47M
Other Income/Expenses
C$ -638.00KC$ -169.00KC$ -171.00KC$ 124.68KC$ -302.00K
Pretax Income
C$ -2.62MC$ -2.50MC$ -4.75MC$ -6.54MC$ -7.77M
Net Income
C$ -2.62MC$ -2.50MC$ -5.24MC$ -6.29MC$ -7.77M
Per Share Metrics
Basic EPS
C$ -0.03C$ -0.03C$ -0.07C$ -0.11C$ -0.24
Diluted EPS
C$ -0.03C$ -0.03C$ -0.07C$ -0.11C$ -0.24
Weighted Average Shares Outstanding
95.06M 82.50M 69.98M 57.45M 32.24M
Weighted Average Shares Outstanding (Diluted)
95.06M 82.50M 69.98M 57.45M 32.24M
Currency in CAD

Hemostemix Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis